Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin plus exercise for sarcopenia in sedentary older adults
ACTRN12624000790549Phase 2Completed
- Sponsor
- Dr Brad Stanfield
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Sarcopenia comparing Sirolimus + exercise with Placebo + exercise (2 arms). Primary endpoint: Change in muscle strength and endurance after exercise program. Started Aug 2024; status: completed.
02
Drugs
sirolimus
03
Conditions
Sarcopenia
Beyond the preview
Go deeper on ACTRN12624000790549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000790549.